Articles related to URINARY TRACT INFECTIONS (UTIs)

Urine color can serve as a valuable diagnostic tool, offering insights into a patient’s hydration level and potential underlying health issues. Understanding these variations is essential for timely and accurate diagnosis.

Explore groundbreaking therapies in the pipeline: Onivyde for pancreatic cancer, showing marked survival benefits, and roluperidone, offering new hope in managing schizophrenia’s negative symptoms.

Clinical risk scores, as highlighted in a recent study, may provide a valuable tool for physicians in optimizing antibiotic treatment strategies for adult outpatients with cUTIs.

Find out more about the concerning trend in the treatment of uncomplicated UTIs at emergency departments, and discover why so many patients may not be receiving the IDSA-recommended treatment.

As published in Cochrane Reviews, cranberry products reduce the risk of repeat symptomatic UTIs in women by more than a quarter. In children and individuals susceptible to UTI following medical interventions, the risk reduction is greater than 50%.

This study randomly assigned participants to receive daily, low-dose antibiotic prophylaxis (n=120) or methenamine hippurate (n=120) for 12 months. Treatment allocation was not masked, and crossover between arms was permitted. The primary clinical outcome measure was the incidence of symptomatic, antibiotic-treated UTI episodes reported by participants over the treatment period. The urinary antiseptic methenamine hippurate was found to be noninferior to prophylactic antibiotics in preventing urinary tract infections (UTIs) in women who had them repeatedly. Results were published March 9 by The British Medical Journal (BMJ).